InvestorsHub Logo
Followers 35
Posts 182
Boards Moderated 0
Alias Born 05/03/2020

Re: None

Saturday, 06/20/2020 3:30:46 PM

Saturday, June 20, 2020 3:30:46 PM

Post# of 402724
It seems people are still shocked by how great the lung results came in. Well, a very few weren't and pretty much knew it will be guaranteed success! ;)

I believe our mc will have a massive run to 400m to 600m... with the grant and phase II trial being announced. It seems that MODERATE cv19 is the ideal target. But if we get a bigger grant enough to run both mild and moderate, watch out World! I'm pegging our valuation to be trading close to $1.2b. It seems the version of nasal spray for mild case will be ideal if the oral version takes longer to produce.

Leo can possibly seek convertible preferreds for $10m to $20m in order to fund or just seek out PPF alternative and initiate a third and/or fourth phase II trials as well for severe and/or mild Cv19 patients. And on top of getting uplisted to NASDAQ.
I also believe that compassionate care usage of Bril in critically patients should be a great choice as a feeler to test the water first, before jumping straight to critically patients. But I tell you what, this Bril drug should work and will have a significant impact in reduced mortality rate! Going straight to critically ill patients will be a huge feat. A min 20% to 25% reduction in mortality rate will be statistically significant. Bril + ventilator vs Remde + ventilator for placebo. Lol.

After phase II results come back, then Leo can strike a deal with PFE if it makes business sense. Can you imagine having two or four cv19 pipelines?? And what that would do to our valuation? That's an easy $3b without phase II RESULTS coming out yet.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News